Results 211 to 220 of about 1,372,313 (313)
Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak +2 more
wiley +1 more source
Evaluating the Feasibility of Electronic Patient-Reported Outcomes for a Population Receiving Specific Health Checkups: A Pilot Study. [PDF]
Yano H +6 more
europepmc +1 more source
Abstract Aims The rising prevalence of diabetes in young adults threatens global health and sustainable development. However, its full macroeconomic impact, especially the welfare losses beyond conventional productivity costs, has not been systematically quantified at a global level. We aimed to estimate the current and future global economic burden of
Hang Guo +3 more
wiley +1 more source
A Rare Case of Cutaneous Leiomyosarcoma Arising From the External Auditory Canal. [PDF]
Yamashita J +4 more
europepmc +1 more source
BABAD PAKUAN ( GURU GANTANGAN ) SEBAGAI IDE BERKARYA BONEKA PERTUNJUKAN KERAMIK [PDF]
Mia Meilia
openalex
ABSTRACT Since there are currently few antiviral drugs that can effectively reduce hepatitis B surface antigen levels, the recurrence rate remains high in patients with chronic hepatitis B (CHB) after discontinuing nucleoside analogues (NAs) treatment.
Dong‐Hui Wang +8 more
wiley +1 more source
Major adverse kidney events in children requiring continuous kidney replacement therapy: a single-center retrospective study in Japan. [PDF]
Tokuda Y +6 more
europepmc +1 more source
ABSTRACT The global elimination of viral hepatitis by 2030 remains an ambitious goal that hinges not only on diagnostics and therapeutics but fundamentally on the strategic use and continued innovation of vaccines. The ESCMID Study Group for Viral Hepatitis (ESGVH) convened to examine the role of vaccination as the cornerstone of hepatitis prevention ...
Oana Săndulescu +5 more
wiley +1 more source
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial. [PDF]
Jamil Y +18 more
europepmc +1 more source

